Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
While new and groundbreaking innovations in biotechnology are developed in laboratories, it is crucial that scientists employ the highest level of safety measures within the laboratory to prevent any unintentional effects on human health or environment. To that end, researchers are developing and making available to the public a proactive, biosafety process to review all proposed biotechnology research and manage potential risks preemptively. Increasingly, scientists across the world and in the Unites States are reporting new and groundbreaking innovations in biotechnology with transformative implications in human health and environmental sustainability. While these technologies are developed in laboratories, researchers are not only giving utmost consideration to the potential beneficial impacts but also to a new set of potential risks arising in synthetic biology research. It is crucial that scientists employ the highest level of safety measures within the laboratory to prevent any unintentional effects on human health or environment. To that end, a proactive biosafety process to review all proposed biotechnology research and manage potential risks pre-emptively, thereby ensuring the appropriate controls are in place throughout all experiments.
For more details: www.sciencedaily.com/releases/2015/05/150506111207.htm
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi